infantis within the ascending (184.51 +/- 17.30% versus 53.83 +/- 17.82%; p < 0.05), transverse (174.79 +/- 25.32% versus 73.17 +/- 15.30%; p < 0.05) and descending (94.90 +/- 25.22% versus 46.37 +/- 18.93%; p > 0.05) colonic microbiota.”
“Objective: To find optimal 100-g 3-h oral glucose tolerance test (OGTT) threshold levels for diagnosis of gestational diabetes (GDM) in Turkish pregnant women. Methods: This study was conducted with 808 women screened for GDM between

24-28 weeks of gestation using the 1-h 50-g glucose challenge test (GCT) with a subsequent 3-h 100-g OGTT for confirmation if screen was positive. The glucose values obtained were analysed by both the Carpenter and Coustan (C&C criteria)

and National Diabetes Data Group (NDDG) criteria for the diagnosis of GDM and IGT. Optimal OGTT cutoff values Z-DEVD-FMK for Turkish population were calculated by ROC curve analysis. Results: The new diagnostic criteria, based on the result of the 100-g OGTT obtained from the healthy pregnant women, were 82.5, 171.5, 151.5, and 111.5 mg/dl at 0, 1, 2, and 3 h. The prevalence of GDM was 15.7% by the new criteria, 8.1% by C&C criteria, and 5.6% by the NDDG criteria. According to new criteria, 7.7% of infants of diabetic mothers had macrosomia. This ratio was 2.6% for non diabetic women. Conclusions: Ethnic differences, enviromental factors and nutritional habits may effect development of GDM. Application of some pre-determined nomograms to all races and ethnic groups can lead errors.”
“Objectives: To examine the prevalence of patient-pharmacy PXD101 staff communication about medications

for pain and arthritis and to assess disparities in communication by demographic, socioeconomic, and health indicators.

Design: Descriptive, nonexperimental, cross-sectional study.

Setting: Alabama between 2005 and 2007.

Patients: 687 patients participating in the Alabama NSAID Patient Safety Study (age >= 50 years and currently taking a prescription nonsteroidal anti-inflammatory AC220 in vivo drug [NSAID]).

Intervention: Not applicable.

Main outcome measures: Communication with pharmacy staff about prescription and over-the-counter (OTC) NSAIDs was examined before and after adjustment for demographic, socioeconomic, and health indicators.

Results: For the entire cohort (n = 687), mean (+/- SD) age was 68.3 +/- 10.0 years, 72.8% were women, 36.4% were black, and 31.2% discussed use of prescription pain/arthritis medications with pharmacy staff. Discussing use of prescription pain/arthritis medications with pharmacy staff differed by race/gender (P < 0.001): white men (40.3%), white women (34.6%), black men (30.2%), and black women (19.8%). Even after multivariable adjustment, black women had the lowest odds of discussing their medications with pharmacy staff (odds ratio 0.40 [95% CI 0.24-0.56]) compared with white men. For the 63.